Skip to main content
TipRanks
Go Ultimate75% OFF

Shanghai Pharmaceuticals Holding Co (2607) Financial Statements

5 Followers

Shanghai Pharmaceuticals Holding Co Financial Overview

Shanghai Pharmaceuticals Holding Co's market cap is currently ¥64.31B. The company's EPS TTM is ¥1.38; its P/E ratio is 11.88; and it has a dividend yield of 5.93%. Shanghai Pharmaceuticals Holding Co is estimated to report earnings on April 1, 2027, and the estimated EPS forecast is ¥0.32. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Mar 24Dec 22Dec 21
Income Statement
Total Revenue¥ 283.58B¥ 275.25B¥ 260.30B¥ 231.98B¥ 215.82B
Gross Profit¥ 30.42B¥ 30.63B¥ 30.93B¥ 30.49B¥ 28.54B
Operating Income¥ 9.94B¥ 8.14B¥ 7.67B¥ 9.01B¥ 8.21B
EBITDA¥ 14.37B¥ 12.06B¥ 10.90B¥ 12.44B¥ 10.55B
Net Income¥ 5.72B¥ 4.55B¥ 3.77B¥ 5.62B¥ 5.09B
Balance Sheet
Cash & Short-Term Investments¥ 43.08B¥ 44.38B¥ 40.67B¥ 37.01B¥ 22.39B
Total Assets¥ 233.15B¥ 221.21B¥ 211.97B¥ 198.13B¥ 163.44B
Total Debt¥ 49.48B¥ 47.79B¥ 42.90B¥ 38.56B¥ 31.69B
Net Debt¥ 16.76B¥ 12.05B¥ 12.38B¥ 11.16B¥ 9.30B
Total Liabilities¥ 143.36B¥ 137.47B¥ 131.65B¥ 120.13B¥ 104.37B
Stockholders' Equity¥ 75.89B¥ 71.68B¥ 68.52B¥ 67.06B¥ 49.36B
Cash Flow
Free Cash Flow¥ 3.83B¥ 3.43B¥ 2.26B¥ 2.06B¥ 942.55M
Operating Cash Flow¥ 6.15B¥ 5.83B¥ 5.23B¥ 4.74B¥ 5.06B
Investing Cash Flow¥ -3.98B¥ 415.98M¥ -2.49B¥ -12.47B¥ -6.02B
Financing Cash Flow¥ -5.65B¥ -1.86B¥ 231.85M¥ 12.14B¥ 1.57B

Currency in CNY

Shanghai Pharmaceuticals Holding Co Earnings and Revenue History

0100B200B300B1.2 %1.8 %2.4 %3 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Shanghai Pharmaceuticals Holding Co Liabilities to Assets

0100B200B300B57.5 %60 %62.5 %65 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Shanghai Pharmaceuticals Holding Co Cash Flow

-15B-10B-5B05B10B15B201720182019202020212022202320242025OperatingInvestingFinancing

Shanghai Pharmaceuticals Holding Co Forecast EPS vs Actual EPS

00.20.40.60.81Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss